Fig. 3: Effect of mRNA booster vaccination on antibody and inhibition levels.
From: Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
A Anti-Spike-RBD antibody and ACE2-Spike binding inhibition before and after an mRNA booster in persons vaccinated with Ad26.COV2.S in comparison to two dose BNT162b2 vaccination. B Anti-Spike-RBD antibody levels in persons vaccinated with Ad26.COV2.S before and after an mRNA booster. C ACE2-Spike binding inhibition levels in persons vaccinated with Ad26.COV2.S before and after an mRNA booster.
